{"gene":"TLR1","run_date":"2026-06-10T10:51:55","timeline":{"discoveries":[{"year":2007,"finding":"Crystal structure of the human TLR1-TLR2 heterodimer bound to the tri-acylated lipopeptide Pam3CSK4 revealed an 'm'-shaped heterodimer: the two ester-bound lipid chains insert into a hydrophobic pocket in TLR2, while the amide-bound lipid chain inserts into a hydrophobic channel in TLR1, with an extensive hydrogen-bonding and hydrophobic network stabilizing the heterodimer and bringing the intracellular TIR domains into proximity to initiate signaling.","method":"X-ray crystallography of TLR1-TLR2-Pam3CSK4 ternary complex","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — atomic-resolution crystal structure with functional validation; landmark paper replicated in subsequent structural and functional studies","pmids":["17889651"],"is_preprint":false},{"year":2003,"finding":"TLR1 and TLR2 are physically associated by co-immunoprecipitation independently of ligand; mycobacterial lipoarabinomannan (LAM) and phosphatidylinositol mannosides activate NF-κB only through the combined actions of TLR1 and TLR2. A protein fragment complementation assay showed that LAM alters the physical interaction between the intracellular TIR domains of TLR1 and TLR2 to initiate signaling.","method":"Co-immunoprecipitation; NF-κB luciferase reporter transfection assay; protein fragment complementation assay","journal":"Journal of endotoxin research","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (Co-IP, reporter assay, complementation assay) in one study; replicated by subsequent crystal structure","pmids":["12935358"],"is_preprint":false},{"year":2003,"finding":"TLR1 and TLR2 co-translationally form heterodimeric complexes on the cell surface and in the cytosol, as shown by confocal microscopy. Simultaneous cross-linking of both receptors produces ligand-independent signal transduction. Chimeric TLR domain-swap analysis demonstrated that both extracellular and intracellular (TIR) domains of both TLR1 and TLR2 are required for functional signaling, and that the TIR domain is the area of crucial intracellular TLR1-TLR2 interaction.","method":"Confocal microscopy; receptor cross-linking; chimeric TLR domain-swap analysis; cytokine secretion assay","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods including imaging, cross-linking and domain-swap mutagenesis in a single focused study","pmids":["12975352"],"is_preprint":false},{"year":2006,"finding":"Alanine scanning mutagenesis of the TLR2 DD loop identified four residues (Arg-748, Phe-749, Leu-752, Arg-753) crucial for TLR2/TLR1 signaling. Computational docking predicted that Arg-748 and Phe-749 contact Gly-676 in the TLR1 BB loop; rational mutation of TLR1 Gly-676 to Ala or Leu reduced Pam3CSK4-mediated NF-κB activation, confirming this TIR-domain interface.","method":"Random and alanine-scanning mutagenesis; NF-κB reporter assay; computational energy minimization and docking","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis combined with functional assay and structural modeling validated by experimental mutation of TLR1 residue; single lab but multiple orthogonal methods","pmids":["16893894"],"is_preprint":false},{"year":2005,"finding":"Binding of the tri-acylated lipopeptide Pam3CSK4 to CD14 is the initial step in lipopeptide recognition, after which CD14 and the lipopeptide associate with TLR2 and TLR1, targeting TLR2 to a low-mobility signaling complex. This was demonstrated by FRET and FRAP imaging in human cells.","method":"FRET and FRAP imaging; flow cytometry; confocal microscopy","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — biophysical FRET/FRAP directly measured molecular proximity in live cells; multiple methods in one study","pmids":["15714590"],"is_preprint":false},{"year":2013,"finding":"Lipopolysaccharide-binding protein (LBP) and soluble CD14 independently act as mobile carriers that deliver triacylated lipopeptides/lipoproteins to TLR1 and TLR2, enhancing formation of the TLR1·TLR2·lipopeptide ternary complex as measured by size exclusion chromatography; neither LBP nor sCD14 remains physically associated with the final ternary complex.","method":"Size exclusion chromatography of recombinant soluble TLR ectodomains; cell activation assay with synthetic lipopeptide and natural lipoprotein OspA","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with purified proteins and orthogonal functional validation; mechanistically rigorous single-lab study","pmids":["23430250"],"is_preprint":false},{"year":2007,"finding":"The I602S single nucleotide polymorphism within the TLR1 transmembrane domain causes aberrant trafficking of TLR1 to the cell surface and diminished functional responses to bacterial agonists in blood monocytes; the 602S variant but not 602I shows these trafficking and signaling deficiencies when expressed in heterologous systems. The 602S allele is associated with decreased leprosy incidence.","method":"Flow cytometry for surface expression; NF-κB reporter assay in transfected cells; whole-blood cytokine assay; genetic association study","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell biology (trafficking), functional signaling assay, and primary human cell data independently replicated by multiple labs","pmids":["17548585"],"is_preprint":false},{"year":2012,"finding":"A short 6-amino-acid cytoplasmic region adjacent to the transmembrane domain is required for TLR1 cell-surface trafficking; a serine at position 602 (I602S) disrupts this trafficking motif. ER-resident chaperones PRAT4A and PRAT4B act as positive and negative regulators of TLR1 surface trafficking, respectively. IFN-γ treatment of monocytes from 602S homozygotes rescues TLR1 surface expression via induction of PRAT4A.","method":"Receptor deletion and point mutagenesis; flow cytometry; PRAT4A/B overexpression and knockdown; IFN-γ treatment of primary human monocytes","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (mutagenesis, chaperone KD/OE, primary cell rescue) in a focused mechanistic study; single lab but comprehensive","pmids":["22447933"],"is_preprint":false},{"year":2006,"finding":"Meningococcal outer membrane porin PorB binds directly to TLR2 (demonstrated by labeled-PorB binding assay in vitro and on HEK293 cells overexpressing TLR2) and selectively signals through the TLR2/TLR1 heterodimer rather than TLR2/TLR6; TLR1 is required for PorB-induced cell activation in transfected HEK293 cells and murine B cells.","method":"Labeled-protein binding assay; chimeric TLR2/TLR1 and TLR2/TLR6 transfection; NF-κB reporter assay; murine B cell activation assay","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct binding demonstrated in vitro and in cell-based assays, with selectivity confirmed using chimeric receptors; multiple orthogonal methods","pmids":["16455995"],"is_preprint":false},{"year":2007,"finding":"Domain-exchange analysis showed that LRR 9-17 in the extracellular domain of TLR1 mediates responses to Francisella lipoproteins TUL4/FTT1103 and to triacylated lipopeptide; substituting the corresponding TLR6 LRR region with TLR1 LRR 9-17 enables TLR6 to recognize these TLR1-specific ligands.","method":"Chimeric TLR domain-exchange assay; NF-κB reporter assay in transfected cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — systematic domain-swap mutagenesis with functional readout; defines ligand-recognition region of TLR1 extracellular domain","pmids":["18079113"],"is_preprint":false},{"year":2007,"finding":"TLR heterodimerization of TLR2 with TLR1 or TLR6 expands the lipopeptide ligand spectrum but leads to an identical NF-κB/MAPK signaling pattern; all TLR2 dimers use the same downstream cascade and produce the same gene activation profile.","method":"Dominant-negative signaling molecule expression; immunoblotting of MAPKs; microarray gene expression analysis","journal":"Journal of leukocyte biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple methods (DN constructs, immunoblot, microarray) in a single lab study; finding that signaling pathways are identical is well-supported","pmids":["18056480"],"is_preprint":false},{"year":2006,"finding":"Triacylated lipopeptides require TLR1 for cellular responses only when the ester-bound fatty acid chains are of sufficient length; short ester-bound chains render triacylated lipopeptides TLR1-independent. Diacylated lipopeptides can be recognized by TLR2 in a TLR1- and TLR6-independent manner, contradicting the strict acylation-pattern model.","method":"Cytokine production assay in TLR1-deficient and TLR6-deficient mouse cells; structure-activity analysis of synthetic lipopeptide analogs","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — systematic use of TLR-KO mice and structural lipopeptide variants; single lab but well-controlled","pmids":["16455646"],"is_preprint":false},{"year":2001,"finding":"TLR1 inhibits TLR2-mediated responses to phenol-soluble modulin from Staphylococcus epidermidis; co-expression of TLR1 with TLR2 dampens signaling relative to TLR2 alone or TLR2/TLR6, showing a negative modulatory role for TLR1 in certain TLR2 ligand contexts.","method":"Transfection-based NF-κB reporter assay; cytokine measurement","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct functional interaction demonstrated in transfection system with defined ligand; replicated by subsequent studies showing context-dependency","pmids":["11123271"],"is_preprint":false},{"year":2002,"finding":"TLR1-deficient mice produce low anti-OspA antibody titers after vaccination and their macrophages fail to respond to OspA (a triacylated lipoprotein) but respond normally to peptidoglycan, establishing TLR1 as required for lipoprotein recognition but dispensable for PGN recognition.","method":"TLR1-/- and TLR2-/- mouse immunization; macrophage cytokine production assay; flow cytometry for TLR1 surface expression on human monocytes","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with specific ligand discrimination in both murine and human systems; replicated and extended in many subsequent studies","pmids":["12091878"],"is_preprint":false},{"year":2015,"finding":"Higher-order oligomeric α-synuclein directly engages the TLR1/2 heterodimer at the microglial cell membrane, triggering MyD88-dependent NF-κB nuclear translocation and production of TNF-α and IL-1β; blocking TLR1/2 with the small-molecule inhibitor CU-CPT22 or inhibiting TLR2 expression with candesartan reduces these responses.","method":"TLR1/2 blocking with CU-CPT22; candesartan treatment; NF-κB translocation assay; cytokine ELISA; primary mouse microglia culture","journal":"Science signaling","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological blockade and small-molecule inhibitor in primary cells; single lab, two orthogonal inhibitory approaches","pmids":["25969543"],"is_preprint":false},{"year":2012,"finding":"The small molecule CU-CPT22 competes with Pam3CSK4 for binding to the TLR1/2 complex with high inhibitory activity and specificity, suppressing downstream TNF-α and IL-1β signaling, establishing TLR1/2 as a druggable target with a defined lipopeptide-binding site.","method":"Competitive binding assay; NF-κB reporter assay; cytokine ELISA in THP-1 cells","journal":"Angewandte Chemie","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — competitive inhibition demonstrates defined binding site; single lab, two methods (binding + functional)","pmids":["22969053"],"is_preprint":false},{"year":2015,"finding":"A small molecule CU-T12-9 directly binds to both TLR1 and TLR2 (demonstrated by fluorescence anisotropy showing competitive binding with Pam3CSK4 at IC50 = 54.4 nM), facilitates TLR1/2 heterodimeric complex formation, and activates downstream NF-κB signaling leading to TNF-α, IL-10, and iNOS production; specificity was confirmed by antibody blocking of TLR1 or TLR2 but not TLR6.","method":"Fluorescence anisotropy competitive binding assay; NF-κB reporter assay; anti-TLR antibody blocking; cytokine ELISA","journal":"Science advances","confidence":"Medium","confidence_rationale":"Tier 1-2 / Moderate — biophysical binding assay plus functional assay with antibody specificity controls; single lab","pmids":["26101787"],"is_preprint":false},{"year":2019,"finding":"Crystal structure of the TLR2/TLR1 agonist Diprovocim revealed two Diprovocim molecules bound in the ligand-binding pocket formed between two TLR2 ectodomains; Diprovocim induces both TLR2/TLR1 heterodimers and TLR2 homodimers in vitro, via extensive hydrophobic interactions and hydrogen bonding, providing structural insight into TLR2/TLR1 activation by a noncanonical non-lipopeptide agonist.","method":"Crystal structure determination; in vitro biophysical assays; computational approaches","journal":"Journal of medicinal chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — atomic resolution crystal structure combined with biophysical validation; single lab but rigorous structural evidence","pmids":["30829478"],"is_preprint":false},{"year":2009,"finding":"The pentameric B subunit of type IIb E. coli enterotoxin (LT-IIb-B5) activates TLR2/TLR1; four residues in the upper pore region of LT-IIb-B5 (M69E, A70D, L73E, S74D) are critical for binding TLR2 or TLR1, and mutations at the TLR2/1 dimer interface reduce activation by both Pam3CSK4 and LT-IIb-B5. LRR motifs 9-12 in the TLR1 central domain are critical for cooperative activation, and the LT-IIb-B5 binding site partially overlaps with that of Pam3CSK4.","method":"Site-directed mutagenesis of ligand and receptor; NF-κB reporter assay; binding assay; docking analysis","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 1-2 / Moderate — mutagenesis of both ligand and receptor with functional readouts; single lab, multiple orthogonal methods","pmids":["19234193"],"is_preprint":false},{"year":2008,"finding":"The TLR1 I602S (T1805G) polymorphism impairs NF-κB signaling in HEK293 cells stimulated with M. leprae extracts; individuals homozygous for 1805G have significantly reduced cytokine responses to irradiated M. leprae and cell wall extracts in PBMCs, and the 1805G allele is associated with protection from leprosy reversal reaction (OR 0.51), linking TLR1 deficiency to impaired Th1-mediated adaptive immunity.","method":"NF-κB reporter assay in transfected HEK293 cells; PBMC cytokine assay; clinical genetic association study","journal":"PLoS neglected tropical diseases","confidence":"High","confidence_rationale":"Tier 2 / Strong — functional cellular assays plus primary human PBMC data plus clinical cohort; multiple independent lines of evidence in same study","pmids":["18461142"],"is_preprint":false},{"year":2019,"finding":"TLR1/2 activation by Pam3CSK4 in AML cells induces apoptosis via p38 MAPK-dependent Caspase-3 activation and myeloid differentiation via NF-κB; these effects are p53-independent (shown using Trp53-null AML cells) and selective for leukemic vs. normal hematopoietic stem/progenitor cells.","method":"Agonist treatment of primary AML and murine AML cells; p38 MAPK/Caspase-3 assay; NF-κB activation assay; Trp53-/- AML model; in vivo mouse model","journal":"Blood advances","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal mechanistic readouts (apoptosis, differentiation, pathway inhibitors) with genetic p53 controls; single lab","pmids":["29296851"],"is_preprint":false},{"year":2012,"finding":"TLR1 activation in intestinal epithelium is required for induction of TH17 immunity during oral Yersinia enterocolitica infection; TLR2/TLR1-induced IL-6 and IL-23 combined with intestinal TGF-β drives TH17 differentiation, while TLR2/TLR6 drives IL-10+ regulatory T cell responses during both oral and systemic infection.","method":"TLR1-/- and TLR6-/- mouse infection model; cytokine measurement; T cell phenotyping","journal":"The Journal of experimental medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO epistasis in infection model with defined cytokine and T cell readouts; single lab","pmids":["22778390"],"is_preprint":false},{"year":2013,"finding":"TLR1 activation in intestinal epithelium upregulates CCL20, recruiting CCR6+ dendritic cells that produce innate cytokines driving TH17 cells and IgA production during oral Y. enterocolitica infection; neutralization of CCL20 or TLR1 deletion both impair CCR6+ DC recruitment and anti-Yersinia TH17/IgA responses.","method":"TLR1-/- mouse infection model; CCL20 antibody neutralization; dendritic cell phenotyping; IgA measurement","journal":"Mucosal immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO and pharmacological blockade with defined cellular and molecular readouts; single lab","pmids":["23443468"],"is_preprint":false},{"year":2005,"finding":"Mycobacterial lipomannan (LM) induces MMP-9 expression and secretion in human macrophages through a TLR1/TLR2- and CD14-dependent mechanism; LM simultaneously down-regulates TIMP-1, the major endogenous MMP-9 inhibitor.","method":"Anti-TLR1 and anti-TLR2 neutralizing antibody blocking; anti-CD14 blocking; ELISA and zymography for MMP-9; RT-PCR for TIMP-1","journal":"Infection and immunity","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — receptor-blocking antibodies with functional readout in primary and cell-line macrophages; single lab","pmids":["16177394"],"is_preprint":false},{"year":2008,"finding":"The triacylated lipoprotein MG149 from Mycoplasma genitalium activates NF-κB through TLR1 and TLR2; dominant-negative TLR1 but not dominant-negative TLR6 blocks MG149-induced NF-κB activation, and a synthetic triacylated lipopeptide derived from MG149 also signals through TLR1/2.","method":"Dominant-negative TLR constructs; NF-κB reporter assay; Triton X-114 protein fractionation","journal":"Infection and immunity","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — dominant-negative approach with defined TLR specificity; single lab, two lines of evidence (native protein and synthetic lipopeptide)","pmids":["18474641"],"is_preprint":false},{"year":2008,"finding":"TLR1/2 signaling in cystic fibrosis airway neutrophils upregulates TLR5 surface expression through a mechanism dependent on TLR1 and TLR2 cooperation; antibody blocking of TLR1 or TLR2 abrogates the Pam3CSK4-induced TLR5 upregulation, and elevated TLR5 enhances phagocytosis and respiratory burst via IL-8/CXCR1 signaling.","method":"Antibody-blocking experiments; confocal microscopy; flow cytometry; in vitro neutrophil stimulation","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — receptor-blocking antibodies plus imaging and functional assays; single lab","pmids":["18684966"],"is_preprint":false},{"year":2018,"finding":"Defective TLR1 recognition of microbiota-derived ligands by colonic epithelial cells disrupts crypt homeostasis (mucus layer defects, ectopic Paneth cells, increased crypt-base proliferation), increases mucosal-associated and translocating commensal bacteria, and promotes chronic low-grade inflammation mediated by innate lymphoid-like cells that worsen colonic injury.","method":"TLR1-/- mouse model; histology; bacterial culture; innate lymphoid cell phenotyping; colitis injury model","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO with multiple defined cellular and histological phenotypes in a focused study; single lab","pmids":["29794015"],"is_preprint":false},{"year":2019,"finding":"In human primary plasmacytoid dendritic cells (pDCs), TLR1 and TLR2 are expressed and respond to gram-positive bacterial lipoproteins via TLR1/2; upregulation of costimulatory molecules and pro-inflammatory cytokines is TLR1-dependent via MAPK and NF-κB pathways, whereas type I IFN secretion is TLR2-dependent via PI3K, revealing a functional dichotomy within the same heterodimer.","method":"Antibody blocking of TLR1 vs TLR2; pathway inhibitors (MAPK, NF-κB, PI3K); cytokine/IFN ELISA; primary human pDC culture","journal":"PLoS biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological pathway dissection and receptor-specific antibody blocking in primary human cells; single lab, orthogonal inhibitor approaches","pmids":["31017904"],"is_preprint":false},{"year":2015,"finding":"siRNA knockdown of TLR1 (but not TLR6) in bovine endometrial epithelial and stromal cells reduces IL-6 and IL-8 accumulation in response to triacylated lipopeptides, and inhibitors of ERK1/2 or p38 limit IL-6 production; both lipopeptides rapidly induce phosphorylation of ERK1/2, p38, and NF-κB through TLR2/TLR1 heterodimers in endometrial cells.","method":"siRNA knockdown; cytokine ELISA; MAPK/NF-κB phosphorylation assay; kinase inhibitors","journal":"Endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA KD with specific receptor discrimination and downstream pathway analysis; single lab, multiple orthogonal methods","pmids":["24437488"],"is_preprint":false},{"year":2015,"finding":"miR-15a/16 directly binds the 3'-UTR of TLR1 mRNA and reduces TLR1 protein expression in non-small cell lung cancer cells, thereby downregulating NF-κB signaling pathway activity and enhancing radiosensitivity.","method":"Luciferase reporter assay (3'-UTR); miRNA mimic overexpression; immunoblot; NF-κB reporter; in vivo xenograft model","journal":"International journal of radiation oncology, biology, physics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — 3'-UTR reporter assay validates direct miRNA-TLR1 interaction; functional consequences shown in vitro and in vivo; single lab","pmids":["25442346"],"is_preprint":false},{"year":2020,"finding":"The spacing of TLR1/2 ligand nanoclusters on an artificial 'phagocytic synapse' array dictates the proximity of TLR1/2 receptor clusters on macrophage surfaces and consequently the magnitude of pro-inflammatory responses; cell responses plateau when ligand spacing is small enough for receptor nanoclusters to become adjacent, demonstrating a physical integration of spatial ligand cues into TLR1/2 signaling.","method":"DNA nanoarray platform mimicking cell-microbe interface; fluorescence imaging of receptor clustering; cytokine assay","journal":"Science advances","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — novel nanopatterning platform with direct imaging of receptor distribution linked to functional output; single lab","pmids":["33268354"],"is_preprint":false},{"year":2019,"finding":"TLR1/2 activation by Pam3CSK4 increases Fcγ receptor IV (FcγRIV) expression on macrophages, leading to antibody-dependent macrophage-mediated depletion of regulatory T cells in the tumor microenvironment; this mechanism enhances efficacy of anti-CTLA-4 antibody and requires CD4 T cells, CD8 T cells, FcγRIV, and macrophages.","method":"In vivo mouse melanoma model; intratumoral injection; flow cytometry for FcγRIV expression; T cell depletion; tumor-infiltrating leukocyte analysis","journal":"PNAS","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo mechanistic dissection with genetic and cell-depletion controls; single lab","pmids":["31076558"],"is_preprint":false}],"current_model":"TLR1 functions as an obligate co-receptor that heterodimerizes with TLR2 to recognize tri-acylated bacterial lipopeptides and lipoproteins: the amide-bound lipid chain of Pam3CSK4 inserts into a hydrophobic channel in TLR1 while ester-bound chains bind TLR2, bringing their intracellular TIR domains into proximity for MyD88-dependent NF-κB and MAPK signaling; TLR1 surface trafficking is regulated by the chaperones PRAT4A (positive) and PRAT4B (negative) via a short cytoplasmic motif at position 602, and the common I602S polymorphism disrupts this motif to impair cell-surface expression and innate immune responses to mycobacteria and other pathogens."},"narrative":{"mechanistic_narrative":"TLR1 is a pattern-recognition co-receptor that operates as an obligate partner of TLR2, forming a heterodimer that detects tri-acylated bacterial lipopeptides and lipoproteins at the cell surface and initiates innate immune signaling [PMID:17889651, PMID:12091878]. TLR1 and TLR2 physically associate co-translationally, independent of ligand, and the crystal structure of the TLR1-TLR2-Pam3CSK4 complex shows an 'm'-shaped heterodimer in which the amide-bound lipid chain of the ligand inserts into a hydrophobic channel in TLR1 while the ester-bound chains occupy a pocket in TLR2, bringing the intracellular TIR domains into proximity for signaling [PMID:17889651, PMID:12935358, PMID:12975352]. Ligand specificity is conferred by the TLR1 extracellular leucine-rich-repeat region (LRR 9-17), which discriminates tri-acylated from di-acylated agonists and distinguishes TLR1- from TLR6-dependent ligands [PMID:18079113, PMID:16455646], while a defined TIR-domain interface (TLR1 Gly-676 contacting the TLR2 DD loop) mediates the productive intracellular interaction [PMID:16893894]. CD14, LBP and soluble CD14 act upstream as mobile carriers that capture lipopeptides and deliver them to the heterodimer, promoting ternary-complex assembly without remaining associated with the final complex [PMID:15714590, PMID:23430250]. Engaged TLR1/2 signals through a MyD88-dependent NF-κB and MAPK (ERK1/2, p38) cascade to drive pro-inflammatory cytokine production [PMID:18056480, PMID:25969543, PMID:24437488]. The receptor recognizes a broad range of microbial ligands—mycobacterial lipoarabinomannan and lipomannan, Francisella and Mycoplasma lipoproteins, Borrelia OspA, meningococcal porin PorB and enterotoxin LT-IIb-B5—and is genetically required for lipoprotein but not peptidoglycan responses [PMID:12935358, PMID:16455995, PMID:18079113, PMID:12091878, PMID:19234193, PMID:16177394, PMID:18474641]. TLR1 cell-surface trafficking depends on a short cytoplasmic motif adjacent to the transmembrane domain and on the ER chaperones PRAT4A (positive) and PRAT4B (negative); the common I602S transmembrane polymorphism disrupts this motif, impairing surface expression and innate responses, an association linked to leprosy susceptibility and rescued by IFN-γ-induced PRAT4A [PMID:17548585, PMID:22447933, PMID:18461142]. Beyond innate sensing, TLR1/2 engagement shapes adaptive and tissue immunity—driving intestinal TH17 differentiation and IgA via epithelial IL-6/IL-23 and CCL20-dependent dendritic-cell recruitment, and maintaining colonic crypt homeostasis through recognition of microbiota ligands [PMID:22778390, PMID:23443468, PMID:29794015].","teleology":[{"year":2001,"claim":"Before TLR1's activating role was defined, its first characterized effect was to negatively modulate TLR2 signaling, establishing that TLR1 is a context-dependent modifier of TLR2 responses rather than a uniform amplifier.","evidence":"Transfection-based NF-κB reporter and cytokine assays with phenol-soluble modulin","pmids":["11123271"],"confidence":"Medium","gaps":["Does not define the ligands for which TLR1 is activating versus inhibitory","Mechanism of the dampening effect unresolved"]},{"year":2002,"claim":"Genetic deletion established TLR1 as specifically required for recognition of tri-acylated lipoproteins while dispensable for peptidoglycan, separating its ligand class from other TLR2 functions.","evidence":"TLR1-/- and TLR2-/- mouse immunization with OspA and macrophage cytokine assays","pmids":["12091878"],"confidence":"High","gaps":["Did not define the structural basis of ligand discrimination","Downstream pathway not dissected"]},{"year":2003,"claim":"Co-IP, imaging and domain-swap analyses showed TLR1 and TLR2 form a ligand-independent heterodimer whose TIR domains are the crucial intracellular interaction surface, defining the receptor as an obligate dimer rather than two independent sensors.","evidence":"Co-immunoprecipitation, confocal microscopy, receptor cross-linking, chimeric domain-swap and complementation assays","pmids":["12935358","12975352"],"confidence":"High","gaps":["Atomic geometry of the dimer not yet resolved","How ligand binding repositions the TIR domains not directly shown"]},{"year":2005,"claim":"Live-cell biophysics placed CD14 upstream as the initial lipopeptide-binding step that recruits the ligand to a TLR1/TLR2 low-mobility signaling complex, ordering the recognition cascade.","evidence":"FRET/FRAP imaging and flow cytometry in human cells with Pam3CSK4","pmids":["15714590"],"confidence":"High","gaps":["Stoichiometry of the CD14-TLR complex not defined","Whether CD14 dissociates from the final complex not addressed here"]},{"year":2006,"claim":"Mutagenesis and docking identified the specific TIR-domain interface residues (TLR1 Gly-676 / TLR2 DD loop) required for productive signaling, localizing the intracellular interaction at amino-acid resolution.","evidence":"Alanine-scanning mutagenesis, computational docking and NF-κB reporter assays","pmids":["16893894"],"confidence":"High","gaps":["Interface mapped computationally rather than by structure","Recruitment of MyD88 to this interface not directly shown"]},{"year":2006,"claim":"Structure-activity analysis with lipopeptide variants and TLR-KO cells refined the acylation model, showing TLR1 dependence requires sufficiently long ester-bound chains and that some di-acylated ligands signal independently of TLR1/TLR6.","evidence":"Cytokine assays in TLR1-/- and TLR6-/- mouse cells with synthetic lipopeptide analogs","pmids":["16455646"],"confidence":"Medium","gaps":["Structural explanation for chain-length requirement provided later by crystallography","Generality across natural ligands not established"]},{"year":2007,"claim":"The crystal structure of the TLR1-TLR2-Pam3CSK4 complex provided the atomic basis for heterodimer assembly and lipid discrimination, showing the amide-bound chain inserts into a hydrophobic channel in TLR1 to bridge the TIR domains.","evidence":"X-ray crystallography of the ternary ectodomain complex with functional validation","pmids":["17889651"],"confidence":"High","gaps":["Does not capture the transmembrane or intracellular conformational changes","CD14/LBP delivery step not in the structure"]},{"year":2007,"claim":"Domain-exchange analysis localized ligand recognition to TLR1 extracellular LRR 9-17, the region that confers specificity for tri-acylated lipopeptides and Francisella lipoproteins.","evidence":"Chimeric TLR1/TLR6 domain-exchange and NF-κB reporter assays","pmids":["18079113"],"confidence":"High","gaps":["Individual contact residues within the region not all mapped","Affinity contributions of the LRR region not quantified"]},{"year":2007,"claim":"Identification of the I602S transmembrane polymorphism linked a natural human variant to defective TLR1 surface trafficking and diminished agonist responses, connecting receptor cell biology to disease susceptibility.","evidence":"Flow cytometry, NF-κB reporter, whole-blood cytokine assays and a leprosy genetic association study","pmids":["17548585"],"confidence":"High","gaps":["Molecular trafficking machinery not yet identified","Mechanism by which a transmembrane residue controls surface delivery unresolved"]},{"year":2008,"claim":"Functional and clinical analysis tied the I602S (1805G) allele to impaired NF-κB responses to M. leprae and to altered leprosy reversal-reaction risk, extending the trafficking defect to adaptive Th1 immunity.","evidence":"NF-κB reporter in HEK293, PBMC cytokine assays and a clinical genetic cohort","pmids":["18461142"],"confidence":"High","gaps":["Causal chain from reduced surface TLR1 to Th1 outcome correlative","Effect sizes vary across pathogen contexts"]},{"year":2012,"claim":"Mechanistic dissection identified the short cytoplasmic trafficking motif disrupted by I602S and the opposing ER chaperones PRAT4A and PRAT4B, and showed IFN-γ rescues surface expression in variant monocytes, defining the regulatory logic of TLR1 surface delivery.","evidence":"Point mutagenesis, PRAT4A/B overexpression and knockdown, and IFN-γ treatment of primary human monocytes","pmids":["22447933"],"confidence":"High","gaps":["Direct chaperone-TLR1 contact sites not mapped","How the cytoplasmic motif is read by the trafficking machinery unresolved"]},{"year":2013,"claim":"In vitro reconstitution defined LBP and soluble CD14 as independent mobile carriers that transfer lipopeptides to the receptor and enhance ternary-complex formation without remaining bound, refining the ligand-delivery model.","evidence":"Size-exclusion chromatography of recombinant soluble TLR ectodomains with cell activation assays","pmids":["23430250"],"confidence":"High","gaps":["Kinetics of carrier handoff not quantified","Relative contributions of LBP versus sCD14 in vivo unclear"]},{"year":2019,"claim":"Crystallography of the synthetic agonist Diprovocim showed a non-lipopeptide ligand can drive TLR2/TLR1 dimerization through the TLR2 ectodomain pocket, establishing that the receptor can be activated by non-canonical chemistries.","evidence":"Crystal structure and in vitro biophysical assays of the TLR2-Diprovocim complex","pmids":["30829478"],"confidence":"High","gaps":["TLR1's contribution to the Diprovocim-bound complex less defined than in the lipopeptide structure","In vivo activity not addressed"]},{"year":null,"claim":"How TLR1's defined molecular recognition is translated into the divergent tissue- and disease-specific outcomes (TH17 versus regulatory responses, leukemic apoptosis, anti-tumor macrophage reprogramming, crypt homeostasis) at the level of signaling specificity remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["Whether identical NF-κB/MAPK output can account for divergent cell-type outcomes is unexplained","No structural model linking ligand identity to differential downstream programs","Mechanism of the receptor-level TLR1/TLR2 functional dichotomy in pDCs not defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,1,13]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[0,5,11]},{"term_id":"GO:0001618","term_label":"virus receptor activity","supporting_discovery_ids":[8,18]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[2,4,6,30]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[7]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[2]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,1,13,27]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[10,14,28]}],"complexes":["TLR1-TLR2 heterodimer"],"partners":["TLR2","CD14","LBP","MYD88","PRAT4A","PRAT4B"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q15399","full_name":"Toll-like receptor 1","aliases":["Toll/interleukin-1 receptor-like protein","TIL"],"length_aa":786,"mass_kda":90.3,"function":"Participates in the innate immune response to microbial agents. Specifically recognizes diacylated and triacylated lipopeptides. Cooperates with TLR2 to mediate the innate immune response to bacterial lipoproteins or lipopeptides (PubMed:21078852). Forms the activation cluster TLR2:TLR1:CD14 in response to triacylated lipopeptides, this cluster triggers signaling from the cell surface and subsequently is targeted to the Golgi in a lipid-raft dependent pathway (PubMed:16880211). Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response","subcellular_location":"Cell membrane; Cytoplasmic vesicle, phagosome membrane; Membrane raft; Golgi apparatus","url":"https://www.uniprot.org/uniprotkb/Q15399/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TLR1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/TLR1","total_profiled":1310},"omim":[{"mim_id":"617553","title":"Fc FRAGMENT OF IgG-BINDING PROTEIN; FCGBP","url":"https://www.omim.org/entry/617553"},{"mim_id":"615492","title":"LONG INTERGENIC NONCODING RNA COX2","url":"https://www.omim.org/entry/615492"},{"mim_id":"613223","title":"LEPROSY, SUSCEPTIBILITY TO, 5; LPRS5","url":"https://www.omim.org/entry/613223"},{"mim_id":"612374","title":"STIMULATOR OF INTERFERON RESPONSE cGAMP INTERACTOR 1; STING1","url":"https://www.omim.org/entry/612374"},{"mim_id":"612112","title":"TUMOR NECROSIS FACTOR-ALPHA-INDUCED PROTEIN 8-LIKE 2; TNFAIP8L2","url":"https://www.omim.org/entry/612112"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"bone marrow","ntpm":32.4},{"tissue":"lymphoid tissue","ntpm":25.4}],"url":"https://www.proteinatlas.org/search/TLR1"},"hgnc":{"alias_symbol":["rsc786","KIAA0012","CD281"],"prev_symbol":[]},"alphafold":{"accession":"Q15399","domains":[{"cath_id":"3.40.50.10140","chopping":"638-777","consensus_level":"high","plddt":82.2146,"start":638,"end":777},{"cath_id":"1.20.5","chopping":"578-608","consensus_level":"high","plddt":82.9568,"start":578,"end":608}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q15399","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q15399-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q15399-F1-predicted_aligned_error_v6.png","plddt_mean":87.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TLR1","jax_strain_url":"https://www.jax.org/strain/search?query=TLR1"},"sequence":{"accession":"Q15399","fasta_url":"https://rest.uniprot.org/uniprotkb/Q15399.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q15399/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q15399"}},"corpus_meta":[{"pmid":"17889651","id":"PMC_17889651","title":"Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide.","date":"2007","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/17889651","citation_count":1073,"is_preprint":false},{"pmid":"11123271","id":"PMC_11123271","title":"Cutting edge: functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin.","date":"2001","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11123271","citation_count":346,"is_preprint":false},{"pmid":"12091878","id":"PMC_12091878","title":"Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice.","date":"2002","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12091878","citation_count":321,"is_preprint":false},{"pmid":"18056480","id":"PMC_18056480","title":"Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling.","date":"2007","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/18056480","citation_count":252,"is_preprint":false},{"pmid":"25969543","id":"PMC_25969543","title":"Activation of MyD88-dependent TLR1/2 signaling by misfolded α-synuclein, a protein linked to neurodegenerative disorders.","date":"2015","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/25969543","citation_count":240,"is_preprint":false},{"pmid":"17548585","id":"PMC_17548585","title":"Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy.","date":"2007","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/17548585","citation_count":213,"is_preprint":false},{"pmid":"16455646","id":"PMC_16455646","title":"TLR1- and TLR6-independent recognition of bacterial lipopeptides.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16455646","citation_count":204,"is_preprint":false},{"pmid":"36398889","id":"PMC_36398889","title":"Lactobacillus johnsonii alleviates colitis by TLR1/2-STAT3 mediated CD206+ macrophagesIL-10 activation.","date":"2022","source":"Gut microbes","url":"https://pubmed.ncbi.nlm.nih.gov/36398889","citation_count":176,"is_preprint":false},{"pmid":"16461792","id":"PMC_16461792","title":"TLR1 and TLR6 polymorphisms are associated with susceptibility to invasive aspergillosis after allogeneic stem cell transplantation.","date":"2005","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/16461792","citation_count":166,"is_preprint":false},{"pmid":"17595679","id":"PMC_17595679","title":"A common human TLR1 polymorphism regulates the innate immune response to lipopeptides.","date":"2007","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17595679","citation_count":161,"is_preprint":false},{"pmid":"22969053","id":"PMC_22969053","title":"Discovery of small-molecule inhibitors of the TLR1/TLR2 complex.","date":"2012","source":"Angewandte Chemie (International ed. in English)","url":"https://pubmed.ncbi.nlm.nih.gov/22969053","citation_count":125,"is_preprint":false},{"pmid":"15812078","id":"PMC_15812078","title":"Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.","date":"2005","source":"Journal of the National Cancer Institute","url":"https://pubmed.ncbi.nlm.nih.gov/15812078","citation_count":124,"is_preprint":false},{"pmid":"20821041","id":"PMC_20821041","title":"TLR1/2, TLR7, and TLR9 signals directly activate human peripheral blood naive and memory B cell subsets to produce cytokines, chemokines, and hematopoietic growth factors.","date":"2010","source":"Journal of clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/20821041","citation_count":124,"is_preprint":false},{"pmid":"15714590","id":"PMC_15714590","title":"Binding of lipopeptide to CD14 induces physical proximity of CD14, TLR2 and TLR1.","date":"2005","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15714590","citation_count":120,"is_preprint":false},{"pmid":"24437488","id":"PMC_24437488","title":"Epithelial and stromal cells of bovine endometrium have roles in innate immunity and initiate inflammatory responses to bacterial lipopeptides in vitro via Toll-like receptors TLR2, TLR1, and TLR6.","date":"2014","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/24437488","citation_count":116,"is_preprint":false},{"pmid":"16455995","id":"PMC_16455995","title":"Meningococcal porin PorB binds to TLR2 and requires TLR1 for signaling.","date":"2006","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/16455995","citation_count":115,"is_preprint":false},{"pmid":"18461142","id":"PMC_18461142","title":"Human TLR1 deficiency is associated with impaired mycobacterial signaling and protection from leprosy reversal reaction.","date":"2008","source":"PLoS neglected tropical diseases","url":"https://pubmed.ncbi.nlm.nih.gov/18461142","citation_count":111,"is_preprint":false},{"pmid":"19641520","id":"PMC_19641520","title":"The TLR1/2 agonist PAM(3)CSK(4) instructs commitment of human hematopoietic stem cells to a myeloid cell fate.","date":"2009","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/19641520","citation_count":106,"is_preprint":false},{"pmid":"30150374","id":"PMC_30150374","title":"Adjuvant effect of the novel TLR1/TLR2 agonist Diprovocim synergizes with anti-PD-L1 to eliminate melanoma in mice.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/30150374","citation_count":100,"is_preprint":false},{"pmid":"16893894","id":"PMC_16893894","title":"Structural and functional evidence for the role of the TLR2 DD loop in TLR1/TLR2 heterodimerization and signaling.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16893894","citation_count":96,"is_preprint":false},{"pmid":"12975352","id":"PMC_12975352","title":"Importance of extra- and intracellular domains of TLR1 and TLR2 in NFkappa B signaling.","date":"2003","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/12975352","citation_count":95,"is_preprint":false},{"pmid":"23430250","id":"PMC_23430250","title":"Human lipopolysaccharide-binding protein (LBP) and CD14 independently deliver triacylated lipoproteins to Toll-like receptor 1 (TLR1) and TLR2 and enhance formation of the ternary signaling complex.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23430250","citation_count":92,"is_preprint":false},{"pmid":"19131114","id":"PMC_19131114","title":"Toll-like receptors TLR1, TLR2 and TLR4 gene mutations and natural resistance to Mycobacterium avium subsp. paratuberculosis infection in cattle.","date":"2008","source":"Veterinary immunology and immunopathology","url":"https://pubmed.ncbi.nlm.nih.gov/19131114","citation_count":90,"is_preprint":false},{"pmid":"12935358","id":"PMC_12935358","title":"Mycobacterial lipoarabinomannan mediates physical interactions between TLR1 and TLR2 to induce signaling.","date":"2003","source":"Journal of endotoxin research","url":"https://pubmed.ncbi.nlm.nih.gov/12935358","citation_count":87,"is_preprint":false},{"pmid":"18079113","id":"PMC_18079113","title":"Identification of Francisella tularensis lipoproteins that stimulate the toll-like receptor (TLR) 2/TLR1 heterodimer.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18079113","citation_count":84,"is_preprint":false},{"pmid":"26430737","id":"PMC_26430737","title":"TLR1, 2, 4, 6 and 9 Variants Associated with Tuberculosis Susceptibility: A Systematic Review and Meta-Analysis.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26430737","citation_count":82,"is_preprint":false},{"pmid":"18036178","id":"PMC_18036178","title":"Role of TLR1 and TLR6 in the host defense against disseminated candidiasis.","date":"2007","source":"FEMS immunology and medical microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/18036178","citation_count":81,"is_preprint":false},{"pmid":"21852947","id":"PMC_21852947","title":"Association of human TLR1 and TLR6 deficiency with altered immune responses to BCG vaccination in South African infants.","date":"2011","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/21852947","citation_count":81,"is_preprint":false},{"pmid":"18752252","id":"PMC_18752252","title":"Genetic variation in the toll-like receptor gene cluster (TLR10-TLR1-TLR6) and prostate cancer risk.","date":"2008","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/18752252","citation_count":79,"is_preprint":false},{"pmid":"26101787","id":"PMC_26101787","title":"Specific activation of the TLR1-TLR2 heterodimer by small-molecule agonists.","date":"2015","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/26101787","citation_count":76,"is_preprint":false},{"pmid":"18684966","id":"PMC_18684966","title":"TLR expression on neutrophils at the pulmonary site of infection: TLR1/TLR2-mediated up-regulation of TLR5 expression in cystic fibrosis lung disease.","date":"2008","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/18684966","citation_count":73,"is_preprint":false},{"pmid":"30829478","id":"PMC_30829478","title":"Structural Basis of TLR2/TLR1 Activation by the Synthetic Agonist Diprovocim.","date":"2019","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30829478","citation_count":71,"is_preprint":false},{"pmid":"19121387","id":"PMC_19121387","title":"Distinct intracellular signaling pathways control the synthesis of IL-8 and RANTES in TLR1/TLR2, TLR3 or NOD1 activated human airway epithelial cells.","date":"2008","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/19121387","citation_count":68,"is_preprint":false},{"pmid":"18474641","id":"PMC_18474641","title":"A triacylated lipoprotein from Mycoplasma genitalium activates NF-kappaB through Toll-like receptor 1 (TLR1) and TLR2.","date":"2008","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/18474641","citation_count":66,"is_preprint":false},{"pmid":"27155354","id":"PMC_27155354","title":"Identification and characteristic analysis of TLR28: A novel member of the TLR1 family in teleost.","date":"2016","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27155354","citation_count":65,"is_preprint":false},{"pmid":"21642391","id":"PMC_21642391","title":"Susceptibility to tuberculosis is associated with TLR1 polymorphisms resulting in a lack of TLR1 cell surface expression.","date":"2011","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/21642391","citation_count":64,"is_preprint":false},{"pmid":"25784622","id":"PMC_25784622","title":"Association of TLR1, TLR2, TLR4, TLR6, and TIRAP polymorphisms with disease susceptibility.","date":"2015","source":"Immunologic research","url":"https://pubmed.ncbi.nlm.nih.gov/25784622","citation_count":61,"is_preprint":false},{"pmid":"31076558","id":"PMC_31076558","title":"TLR1/2 ligand enhances antitumor efficacy of CTLA-4 blockade by increasing intratumoral Treg depletion.","date":"2019","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/31076558","citation_count":60,"is_preprint":false},{"pmid":"22778390","id":"PMC_22778390","title":"A specific role for TLR1 in protective T(H)17 immunity during mucosal infection.","date":"2012","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22778390","citation_count":60,"is_preprint":false},{"pmid":"31131189","id":"PMC_31131189","title":"TLR1/2 Specific Small-Molecule Agonist Suppresses Leukemia Cancer Cell Growth by Stimulating Cytotoxic T Lymphocytes.","date":"2019","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/31131189","citation_count":60,"is_preprint":false},{"pmid":"21619680","id":"PMC_21619680","title":"Molecular evolution of the vertebrate TLR1 gene family--a complex history of gene duplication, gene conversion, positive selection and co-evolution.","date":"2011","source":"BMC evolutionary biology","url":"https://pubmed.ncbi.nlm.nih.gov/21619680","citation_count":59,"is_preprint":false},{"pmid":"24227786","id":"PMC_24227786","title":"TLR1/2 ligand-stimulated mouse liver endothelial cells secrete IL-12 and trigger CD8+ T cell immunity in vitro.","date":"2013","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/24227786","citation_count":58,"is_preprint":false},{"pmid":"23151486","id":"PMC_23151486","title":"Variation in the TLR10/TLR1/TLR6 locus is the major genetic determinant of interindividual difference in TLR1/2-mediated responses.","date":"2012","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/23151486","citation_count":55,"is_preprint":false},{"pmid":"22150367","id":"PMC_22150367","title":"Genetic variation in the Toll-like receptor gene cluster (TLR10-TLR1-TLR6) influences disease course in sarcoidosis.","date":"2012","source":"Tissue antigens","url":"https://pubmed.ncbi.nlm.nih.gov/22150367","citation_count":53,"is_preprint":false},{"pmid":"25442346","id":"PMC_25442346","title":"miR-15a/16 enhances radiation sensitivity of non-small cell lung cancer cells by targeting the TLR1/NF-κB signaling pathway.","date":"2014","source":"International journal of radiation oncology, biology, physics","url":"https://pubmed.ncbi.nlm.nih.gov/25442346","citation_count":51,"is_preprint":false},{"pmid":"25536171","id":"PMC_25536171","title":"B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: modulation by BCR and CD40, and relevance to T-independent antibody responses.","date":"2015","source":"Autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/25536171","citation_count":51,"is_preprint":false},{"pmid":"25903926","id":"PMC_25903926","title":"Molecular cloning of Salmo salar Toll-like receptors (TLR1, TLR22, TLR5M and TLR5S) and expression analysis in SHK-1 cells during Piscirickettsia salmonis infection.","date":"2015","source":"Journal of fish diseases","url":"https://pubmed.ncbi.nlm.nih.gov/25903926","citation_count":51,"is_preprint":false},{"pmid":"28684329","id":"PMC_28684329","title":"House Dust Mite Increases pro-Th2 Cytokines IL-25 and IL-33 via the Activation of TLR1/6 Signaling.","date":"2017","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/28684329","citation_count":51,"is_preprint":false},{"pmid":"21998742","id":"PMC_21998742","title":"TLR1/TLR2 heterodimers play an important role in the recognition of Borrelia spirochetes.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21998742","citation_count":50,"is_preprint":false},{"pmid":"28289440","id":"PMC_28289440","title":"Role of TLR1, TLR2 and TLR6 in the modulation of intestinal inflammation and Candida albicans elimination.","date":"2017","source":"Gut pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/28289440","citation_count":49,"is_preprint":false},{"pmid":"20153434","id":"PMC_20153434","title":"Identification, characterization and genetic mapping of TLR1 loci in rainbow trout (Oncorhynchus mykiss).","date":"2010","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/20153434","citation_count":48,"is_preprint":false},{"pmid":"22822027","id":"PMC_22822027","title":"Atherosclerosis induced by endogenous and exogenous toll-like receptor (TLR)1 or TLR6 agonists.","date":"2012","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/22822027","citation_count":46,"is_preprint":false},{"pmid":"21695103","id":"PMC_21695103","title":"TLR1/2 activation during heterologous prime-boost vaccination (DNA-MVA) enhances CD8+ T Cell responses providing protection against Leishmania (Viannia).","date":"2011","source":"PLoS neglected tropical diseases","url":"https://pubmed.ncbi.nlm.nih.gov/21695103","citation_count":46,"is_preprint":false},{"pmid":"17727694","id":"PMC_17727694","title":"Gene conversion limits divergence of mammalian TLR1 and TLR6.","date":"2007","source":"BMC evolutionary biology","url":"https://pubmed.ncbi.nlm.nih.gov/17727694","citation_count":45,"is_preprint":false},{"pmid":"23861935","id":"PMC_23861935","title":"Innate immune receptors in human airway smooth muscle cells: activation by TLR1/2, TLR3, TLR4, TLR7 and NOD1 agonists.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23861935","citation_count":44,"is_preprint":false},{"pmid":"27832948","id":"PMC_27832948","title":"Up-regulated of miR-8159-5p and miR-217-5p by LPS stimulation negatively co-regulate TLR1 in miiuy croaker.","date":"2016","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27832948","citation_count":43,"is_preprint":false},{"pmid":"16177394","id":"PMC_16177394","title":"Mycobacterial lipomannan induces matrix metalloproteinase-9 expression in human macrophagic cells through a Toll-like receptor 1 (TLR1)/TLR2- and CD14-dependent mechanism.","date":"2005","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/16177394","citation_count":42,"is_preprint":false},{"pmid":"31212097","id":"PMC_31212097","title":"TLR1/TLR2 signaling blocks the suppression of monocytic myeloid-derived suppressor cell by promoting its differentiation into M1-type macrophage.","date":"2019","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31212097","citation_count":41,"is_preprint":false},{"pmid":"18560588","id":"PMC_18560588","title":"Immunogenecity of modified alkane polymers is mediated through TLR1/2 activation.","date":"2008","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/18560588","citation_count":41,"is_preprint":false},{"pmid":"27431585","id":"PMC_27431585","title":"Comparative genomic evidence for duplication of TLR1 subfamily and miiuy croaker TLR1 perceives LPS stimulation via MyD88 and TIRAP.","date":"2016","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27431585","citation_count":40,"is_preprint":false},{"pmid":"24511099","id":"PMC_24511099","title":"TLR1, TLR2, and TLR6 gene polymorphisms are associated with increased susceptibility to complicated skin and skin structure infections.","date":"2014","source":"The Journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/24511099","citation_count":40,"is_preprint":false},{"pmid":"29296851","id":"PMC_29296851","title":"Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NFκB-dependent differentiation of AML cells.","date":"2017","source":"Blood advances","url":"https://pubmed.ncbi.nlm.nih.gov/29296851","citation_count":39,"is_preprint":false},{"pmid":"21048935","id":"PMC_21048935","title":"Common variants of TLR1 associate with organ dysfunction and sustained pro-inflammatory responses during sepsis.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21048935","citation_count":38,"is_preprint":false},{"pmid":"27368535","id":"PMC_27368535","title":"Molecular and functional characterization of Toll-like receptor (Tlr)1 and Tlr2 in common carp (Cyprinus carpio).","date":"2016","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27368535","citation_count":37,"is_preprint":false},{"pmid":"19234193","id":"PMC_19234193","title":"Mapping of a microbial protein domain involved in binding and activation of the TLR2/TLR1 heterodimer.","date":"2009","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/19234193","citation_count":36,"is_preprint":false},{"pmid":"26093918","id":"PMC_26093918","title":"Vibrio cholerae porin OmpU mediates M1-polarization of macrophages/monocytes via TLR1/TLR2 activation.","date":"2015","source":"Immunobiology","url":"https://pubmed.ncbi.nlm.nih.gov/26093918","citation_count":36,"is_preprint":false},{"pmid":"29794015","id":"PMC_29794015","title":"Innate Recognition of the Microbiota by TLR1 Promotes Epithelial Homeostasis and Prevents Chronic Inflammation.","date":"2018","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/29794015","citation_count":36,"is_preprint":false},{"pmid":"33862097","id":"PMC_33862097","title":"Identification and expression analysis of sixteen Toll-like receptor genes, TLR1, TLR2a, TLR2b, TLR3, TLR5M, TLR5S, TLR7-9, TLR13a-c, TLR14, TLR21-23 in mandarin fish Siniperca chuatsi.","date":"2021","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33862097","citation_count":35,"is_preprint":false},{"pmid":"17932345","id":"PMC_17932345","title":"Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer.","date":"2007","source":"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/17932345","citation_count":35,"is_preprint":false},{"pmid":"23443468","id":"PMC_23443468","title":"TLR1-induced chemokine production is critical for mucosal immunity against Yersinia enterocolitica.","date":"2013","source":"Mucosal immunology","url":"https://pubmed.ncbi.nlm.nih.gov/23443468","citation_count":35,"is_preprint":false},{"pmid":"35355415","id":"PMC_35355415","title":"The transcription factors TLR1 and TLR2 negatively regulate trichome density and artemisinin levels in Artemisia annua.","date":"2022","source":"Journal of integrative plant biology","url":"https://pubmed.ncbi.nlm.nih.gov/35355415","citation_count":34,"is_preprint":false},{"pmid":"20667457","id":"PMC_20667457","title":"Correlation of TLR1-10 expression in peripheral blood mononuclear cells with chronic hepatitis B and chronic hepatitis B-related liver failure.","date":"2010","source":"Human immunology","url":"https://pubmed.ncbi.nlm.nih.gov/20667457","citation_count":34,"is_preprint":false},{"pmid":"25544311","id":"PMC_25544311","title":"Toll-like receptor 1(TLR1) Gene SNP rs5743618 is associated with increased risk for tuberculosis in Han Chinese children.","date":"2014","source":"Tuberculosis (Edinburgh, Scotland)","url":"https://pubmed.ncbi.nlm.nih.gov/25544311","citation_count":33,"is_preprint":false},{"pmid":"23826682","id":"PMC_23826682","title":"The molecular basis for recognition of bacterial ligands at equine TLR2, TLR1 and TLR6.","date":"2013","source":"Veterinary research","url":"https://pubmed.ncbi.nlm.nih.gov/23826682","citation_count":33,"is_preprint":false},{"pmid":"27288848","id":"PMC_27288848","title":"miR-200a-3p regulates TLR1 expression in bacterial challenged miiuy croaker.","date":"2016","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27288848","citation_count":32,"is_preprint":false},{"pmid":"28368946","id":"PMC_28368946","title":"Genetic polymorphisms in TLR1, TLR2, TLR4, and TLR10 of Helicobacter pylori-associated gastritis: a prospective cross-sectional study in Thailand.","date":"2018","source":"European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)","url":"https://pubmed.ncbi.nlm.nih.gov/28368946","citation_count":31,"is_preprint":false},{"pmid":"29927962","id":"PMC_29927962","title":"Genome wide analysis of TLR1/2- and TLR4-activated SZ95 sebocytes reveals a complex immune-competence and identifies serum amyloid A as a marker for activated sebaceous glands.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29927962","citation_count":31,"is_preprint":false},{"pmid":"17654751","id":"PMC_17654751","title":"Genomic variants of TLR1--it takes (TLR-)two to tango.","date":"2007","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17654751","citation_count":30,"is_preprint":false},{"pmid":"34029463","id":"PMC_34029463","title":"Design, Synthesis, and Structure-Activity Relationship of N-Aryl-N'-(thiophen-2-yl)thiourea Derivatives as Novel and Specific Human TLR1/2 Agonists for Potential Cancer Immunotherapy.","date":"2021","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/34029463","citation_count":30,"is_preprint":false},{"pmid":"22447933","id":"PMC_22447933","title":"Cell surface trafficking of TLR1 is differentially regulated by the chaperones PRAT4A and PRAT4B.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22447933","citation_count":29,"is_preprint":false},{"pmid":"16950576","id":"PMC_16950576","title":"Genomic organization and transcript profiling of the bovine toll-like receptor gene cluster TLR6-TLR1-TLR10.","date":"2006","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/16950576","citation_count":28,"is_preprint":false},{"pmid":"27059597","id":"PMC_27059597","title":"B Cell Anergy Modulated by TLR1/2 and the miR-17∼92 Cluster Underlies the Indolent Clinical Course of Chronic Lymphocytic Leukemia Stereotyped Subset #4.","date":"2016","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/27059597","citation_count":28,"is_preprint":false},{"pmid":"21618349","id":"PMC_21618349","title":"Functional characterization of naturally occurring genetic variants in the human TLR1-2-6 gene family.","date":"2011","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/21618349","citation_count":26,"is_preprint":false},{"pmid":"32269105","id":"PMC_32269105","title":"Neonatal Stroke and TLR1/2 Ligand Recruit Myeloid Cells through the Choroid Plexus in a CX3CR1-CCR2- and Context-Specific Manner.","date":"2020","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/32269105","citation_count":25,"is_preprint":false},{"pmid":"16783164","id":"PMC_16783164","title":"Borrelia burgdorferi Induces TLR1 and TLR2 in human microglia and peripheral blood monocytes but differentially regulates HLA-class II expression.","date":"2006","source":"Journal of neuropathology and experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/16783164","citation_count":25,"is_preprint":false},{"pmid":"24928324","id":"PMC_24928324","title":"Systemic injection of TLR1/2 agonist improves adoptive antigen-specific T cell therapy in glioma-bearing mice.","date":"2014","source":"Clinical immunology (Orlando, Fla.)","url":"https://pubmed.ncbi.nlm.nih.gov/24928324","citation_count":25,"is_preprint":false},{"pmid":"30574617","id":"PMC_30574617","title":"TLR1 and PRKAA1 Gene Polymorphisms in the Development of Atrophic Gastritis and Gastric Cancer.","date":"2018","source":"Journal of gastrointestinal and liver diseases : JGLD","url":"https://pubmed.ncbi.nlm.nih.gov/30574617","citation_count":24,"is_preprint":false},{"pmid":"31017904","id":"PMC_31017904","title":"TLR1/2 orchestrate human plasmacytoid predendritic cell response to gram+ bacteria.","date":"2019","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/31017904","citation_count":23,"is_preprint":false},{"pmid":"35040862","id":"PMC_35040862","title":"RBD conjugate vaccine with a built-in TLR1/2 agonist is highly immunogenic against SARS-CoV-2 and variants of concern.","date":"2022","source":"Chemical communications (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/35040862","citation_count":23,"is_preprint":false},{"pmid":"23844129","id":"PMC_23844129","title":"Roles for Treg expansion and HMGB1 signaling through the TLR1-2-6 axis in determining the magnitude of the antigen-specific immune response to MVA85A.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23844129","citation_count":23,"is_preprint":false},{"pmid":"34579194","id":"PMC_34579194","title":"COVID-19 Subunit Vaccine with a Combination of TLR1/2 and TLR3 Agonists Induces Robust and Protective Immunity.","date":"2021","source":"Vaccines","url":"https://pubmed.ncbi.nlm.nih.gov/34579194","citation_count":22,"is_preprint":false},{"pmid":"15731092","id":"PMC_15731092","title":"Sublethal infection of C57BL/6 mice with Salmonella enterica Serovar Typhimurium leads to an increase in levels of Toll-like receptor 1 (TLR1), TLR2, and TLR9 mRNA as well as a decrease in levels of TLR6 mRNA in infected organs.","date":"2005","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/15731092","citation_count":22,"is_preprint":false},{"pmid":"33268354","id":"PMC_33268354","title":"Macrophage activation on \"phagocytic synapse\" arrays: Spacing of nanoclustered ligands directs TLR1/2 signaling with an intrinsic limit.","date":"2020","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/33268354","citation_count":21,"is_preprint":false},{"pmid":"26729809","id":"PMC_26729809","title":"A Common Genetic Variant in TLR1 Enhances Human Neutrophil Priming and Impacts Length of Intensive Care Stay in Pediatric Sepsis.","date":"2016","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/26729809","citation_count":21,"is_preprint":false},{"pmid":"28715461","id":"PMC_28715461","title":"TLR1-10, NF-κB and p53 expression is increased in oral lichenoid disease.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28715461","citation_count":20,"is_preprint":false},{"pmid":"27037219","id":"PMC_27037219","title":"Identification and characterization of three TLR1 subfamily members from the orange-spotted grouper, Epinephelus coioides.","date":"2016","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27037219","citation_count":20,"is_preprint":false},{"pmid":"27351455","id":"PMC_27351455","title":"Diabetic pregnancy activates the innate immune response through TLR5 or TLR1/2 on neonatal monocyte.","date":"2016","source":"Journal of reproductive immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27351455","citation_count":20,"is_preprint":false},{"pmid":"9304822","id":"PMC_9304822","title":"Alternate junctions and microheterogeneity of Tlr1, a developmentally regulated DNA rearrangement in Tetrahymena thermophila.","date":"1997","source":"The Journal of eukaryotic microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/9304822","citation_count":20,"is_preprint":false},{"pmid":"20800577","id":"PMC_20800577","title":"Non-acylated Mycobacterium bovis glycoprotein MPB83 binds to TLR1/2 and stimulates production of matrix metalloproteinase 9.","date":"2010","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/20800577","citation_count":20,"is_preprint":false},{"pmid":"26021825","id":"PMC_26021825","title":"TLR1 expression in mouse brain was increased in a KA-induced seizure model.","date":"2015","source":"Inflammation research : official journal of the European Histamine Research Society ... [et al.]","url":"https://pubmed.ncbi.nlm.nih.gov/26021825","citation_count":19,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52830,"output_tokens":8308,"usd":0.141555,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17761,"output_tokens":4633,"usd":0.102315,"stage2_stop_reason":"end_turn"},"total_usd":0.24387,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2007,\n      \"finding\": \"Crystal structure of the human TLR1-TLR2 heterodimer bound to the tri-acylated lipopeptide Pam3CSK4 revealed an 'm'-shaped heterodimer: the two ester-bound lipid chains insert into a hydrophobic pocket in TLR2, while the amide-bound lipid chain inserts into a hydrophobic channel in TLR1, with an extensive hydrogen-bonding and hydrophobic network stabilizing the heterodimer and bringing the intracellular TIR domains into proximity to initiate signaling.\",\n      \"method\": \"X-ray crystallography of TLR1-TLR2-Pam3CSK4 ternary complex\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — atomic-resolution crystal structure with functional validation; landmark paper replicated in subsequent structural and functional studies\",\n      \"pmids\": [\"17889651\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"TLR1 and TLR2 are physically associated by co-immunoprecipitation independently of ligand; mycobacterial lipoarabinomannan (LAM) and phosphatidylinositol mannosides activate NF-κB only through the combined actions of TLR1 and TLR2. A protein fragment complementation assay showed that LAM alters the physical interaction between the intracellular TIR domains of TLR1 and TLR2 to initiate signaling.\",\n      \"method\": \"Co-immunoprecipitation; NF-κB luciferase reporter transfection assay; protein fragment complementation assay\",\n      \"journal\": \"Journal of endotoxin research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (Co-IP, reporter assay, complementation assay) in one study; replicated by subsequent crystal structure\",\n      \"pmids\": [\"12935358\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"TLR1 and TLR2 co-translationally form heterodimeric complexes on the cell surface and in the cytosol, as shown by confocal microscopy. Simultaneous cross-linking of both receptors produces ligand-independent signal transduction. Chimeric TLR domain-swap analysis demonstrated that both extracellular and intracellular (TIR) domains of both TLR1 and TLR2 are required for functional signaling, and that the TIR domain is the area of crucial intracellular TLR1-TLR2 interaction.\",\n      \"method\": \"Confocal microscopy; receptor cross-linking; chimeric TLR domain-swap analysis; cytokine secretion assay\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods including imaging, cross-linking and domain-swap mutagenesis in a single focused study\",\n      \"pmids\": [\"12975352\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Alanine scanning mutagenesis of the TLR2 DD loop identified four residues (Arg-748, Phe-749, Leu-752, Arg-753) crucial for TLR2/TLR1 signaling. Computational docking predicted that Arg-748 and Phe-749 contact Gly-676 in the TLR1 BB loop; rational mutation of TLR1 Gly-676 to Ala or Leu reduced Pam3CSK4-mediated NF-κB activation, confirming this TIR-domain interface.\",\n      \"method\": \"Random and alanine-scanning mutagenesis; NF-κB reporter assay; computational energy minimization and docking\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis combined with functional assay and structural modeling validated by experimental mutation of TLR1 residue; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"16893894\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Binding of the tri-acylated lipopeptide Pam3CSK4 to CD14 is the initial step in lipopeptide recognition, after which CD14 and the lipopeptide associate with TLR2 and TLR1, targeting TLR2 to a low-mobility signaling complex. This was demonstrated by FRET and FRAP imaging in human cells.\",\n      \"method\": \"FRET and FRAP imaging; flow cytometry; confocal microscopy\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — biophysical FRET/FRAP directly measured molecular proximity in live cells; multiple methods in one study\",\n      \"pmids\": [\"15714590\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Lipopolysaccharide-binding protein (LBP) and soluble CD14 independently act as mobile carriers that deliver triacylated lipopeptides/lipoproteins to TLR1 and TLR2, enhancing formation of the TLR1·TLR2·lipopeptide ternary complex as measured by size exclusion chromatography; neither LBP nor sCD14 remains physically associated with the final ternary complex.\",\n      \"method\": \"Size exclusion chromatography of recombinant soluble TLR ectodomains; cell activation assay with synthetic lipopeptide and natural lipoprotein OspA\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with purified proteins and orthogonal functional validation; mechanistically rigorous single-lab study\",\n      \"pmids\": [\"23430250\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The I602S single nucleotide polymorphism within the TLR1 transmembrane domain causes aberrant trafficking of TLR1 to the cell surface and diminished functional responses to bacterial agonists in blood monocytes; the 602S variant but not 602I shows these trafficking and signaling deficiencies when expressed in heterologous systems. The 602S allele is associated with decreased leprosy incidence.\",\n      \"method\": \"Flow cytometry for surface expression; NF-κB reporter assay in transfected cells; whole-blood cytokine assay; genetic association study\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell biology (trafficking), functional signaling assay, and primary human cell data independently replicated by multiple labs\",\n      \"pmids\": [\"17548585\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"A short 6-amino-acid cytoplasmic region adjacent to the transmembrane domain is required for TLR1 cell-surface trafficking; a serine at position 602 (I602S) disrupts this trafficking motif. ER-resident chaperones PRAT4A and PRAT4B act as positive and negative regulators of TLR1 surface trafficking, respectively. IFN-γ treatment of monocytes from 602S homozygotes rescues TLR1 surface expression via induction of PRAT4A.\",\n      \"method\": \"Receptor deletion and point mutagenesis; flow cytometry; PRAT4A/B overexpression and knockdown; IFN-γ treatment of primary human monocytes\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (mutagenesis, chaperone KD/OE, primary cell rescue) in a focused mechanistic study; single lab but comprehensive\",\n      \"pmids\": [\"22447933\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Meningococcal outer membrane porin PorB binds directly to TLR2 (demonstrated by labeled-PorB binding assay in vitro and on HEK293 cells overexpressing TLR2) and selectively signals through the TLR2/TLR1 heterodimer rather than TLR2/TLR6; TLR1 is required for PorB-induced cell activation in transfected HEK293 cells and murine B cells.\",\n      \"method\": \"Labeled-protein binding assay; chimeric TLR2/TLR1 and TLR2/TLR6 transfection; NF-κB reporter assay; murine B cell activation assay\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding demonstrated in vitro and in cell-based assays, with selectivity confirmed using chimeric receptors; multiple orthogonal methods\",\n      \"pmids\": [\"16455995\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Domain-exchange analysis showed that LRR 9-17 in the extracellular domain of TLR1 mediates responses to Francisella lipoproteins TUL4/FTT1103 and to triacylated lipopeptide; substituting the corresponding TLR6 LRR region with TLR1 LRR 9-17 enables TLR6 to recognize these TLR1-specific ligands.\",\n      \"method\": \"Chimeric TLR domain-exchange assay; NF-κB reporter assay in transfected cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — systematic domain-swap mutagenesis with functional readout; defines ligand-recognition region of TLR1 extracellular domain\",\n      \"pmids\": [\"18079113\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"TLR heterodimerization of TLR2 with TLR1 or TLR6 expands the lipopeptide ligand spectrum but leads to an identical NF-κB/MAPK signaling pattern; all TLR2 dimers use the same downstream cascade and produce the same gene activation profile.\",\n      \"method\": \"Dominant-negative signaling molecule expression; immunoblotting of MAPKs; microarray gene expression analysis\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple methods (DN constructs, immunoblot, microarray) in a single lab study; finding that signaling pathways are identical is well-supported\",\n      \"pmids\": [\"18056480\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Triacylated lipopeptides require TLR1 for cellular responses only when the ester-bound fatty acid chains are of sufficient length; short ester-bound chains render triacylated lipopeptides TLR1-independent. Diacylated lipopeptides can be recognized by TLR2 in a TLR1- and TLR6-independent manner, contradicting the strict acylation-pattern model.\",\n      \"method\": \"Cytokine production assay in TLR1-deficient and TLR6-deficient mouse cells; structure-activity analysis of synthetic lipopeptide analogs\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic use of TLR-KO mice and structural lipopeptide variants; single lab but well-controlled\",\n      \"pmids\": [\"16455646\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"TLR1 inhibits TLR2-mediated responses to phenol-soluble modulin from Staphylococcus epidermidis; co-expression of TLR1 with TLR2 dampens signaling relative to TLR2 alone or TLR2/TLR6, showing a negative modulatory role for TLR1 in certain TLR2 ligand contexts.\",\n      \"method\": \"Transfection-based NF-κB reporter assay; cytokine measurement\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct functional interaction demonstrated in transfection system with defined ligand; replicated by subsequent studies showing context-dependency\",\n      \"pmids\": [\"11123271\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"TLR1-deficient mice produce low anti-OspA antibody titers after vaccination and their macrophages fail to respond to OspA (a triacylated lipoprotein) but respond normally to peptidoglycan, establishing TLR1 as required for lipoprotein recognition but dispensable for PGN recognition.\",\n      \"method\": \"TLR1-/- and TLR2-/- mouse immunization; macrophage cytokine production assay; flow cytometry for TLR1 surface expression on human monocytes\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with specific ligand discrimination in both murine and human systems; replicated and extended in many subsequent studies\",\n      \"pmids\": [\"12091878\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Higher-order oligomeric α-synuclein directly engages the TLR1/2 heterodimer at the microglial cell membrane, triggering MyD88-dependent NF-κB nuclear translocation and production of TNF-α and IL-1β; blocking TLR1/2 with the small-molecule inhibitor CU-CPT22 or inhibiting TLR2 expression with candesartan reduces these responses.\",\n      \"method\": \"TLR1/2 blocking with CU-CPT22; candesartan treatment; NF-κB translocation assay; cytokine ELISA; primary mouse microglia culture\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological blockade and small-molecule inhibitor in primary cells; single lab, two orthogonal inhibitory approaches\",\n      \"pmids\": [\"25969543\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The small molecule CU-CPT22 competes with Pam3CSK4 for binding to the TLR1/2 complex with high inhibitory activity and specificity, suppressing downstream TNF-α and IL-1β signaling, establishing TLR1/2 as a druggable target with a defined lipopeptide-binding site.\",\n      \"method\": \"Competitive binding assay; NF-κB reporter assay; cytokine ELISA in THP-1 cells\",\n      \"journal\": \"Angewandte Chemie\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — competitive inhibition demonstrates defined binding site; single lab, two methods (binding + functional)\",\n      \"pmids\": [\"22969053\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"A small molecule CU-T12-9 directly binds to both TLR1 and TLR2 (demonstrated by fluorescence anisotropy showing competitive binding with Pam3CSK4 at IC50 = 54.4 nM), facilitates TLR1/2 heterodimeric complex formation, and activates downstream NF-κB signaling leading to TNF-α, IL-10, and iNOS production; specificity was confirmed by antibody blocking of TLR1 or TLR2 but not TLR6.\",\n      \"method\": \"Fluorescence anisotropy competitive binding assay; NF-κB reporter assay; anti-TLR antibody blocking; cytokine ELISA\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — biophysical binding assay plus functional assay with antibody specificity controls; single lab\",\n      \"pmids\": [\"26101787\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Crystal structure of the TLR2/TLR1 agonist Diprovocim revealed two Diprovocim molecules bound in the ligand-binding pocket formed between two TLR2 ectodomains; Diprovocim induces both TLR2/TLR1 heterodimers and TLR2 homodimers in vitro, via extensive hydrophobic interactions and hydrogen bonding, providing structural insight into TLR2/TLR1 activation by a noncanonical non-lipopeptide agonist.\",\n      \"method\": \"Crystal structure determination; in vitro biophysical assays; computational approaches\",\n      \"journal\": \"Journal of medicinal chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — atomic resolution crystal structure combined with biophysical validation; single lab but rigorous structural evidence\",\n      \"pmids\": [\"30829478\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The pentameric B subunit of type IIb E. coli enterotoxin (LT-IIb-B5) activates TLR2/TLR1; four residues in the upper pore region of LT-IIb-B5 (M69E, A70D, L73E, S74D) are critical for binding TLR2 or TLR1, and mutations at the TLR2/1 dimer interface reduce activation by both Pam3CSK4 and LT-IIb-B5. LRR motifs 9-12 in the TLR1 central domain are critical for cooperative activation, and the LT-IIb-B5 binding site partially overlaps with that of Pam3CSK4.\",\n      \"method\": \"Site-directed mutagenesis of ligand and receptor; NF-κB reporter assay; binding assay; docking analysis\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — mutagenesis of both ligand and receptor with functional readouts; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"19234193\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The TLR1 I602S (T1805G) polymorphism impairs NF-κB signaling in HEK293 cells stimulated with M. leprae extracts; individuals homozygous for 1805G have significantly reduced cytokine responses to irradiated M. leprae and cell wall extracts in PBMCs, and the 1805G allele is associated with protection from leprosy reversal reaction (OR 0.51), linking TLR1 deficiency to impaired Th1-mediated adaptive immunity.\",\n      \"method\": \"NF-κB reporter assay in transfected HEK293 cells; PBMC cytokine assay; clinical genetic association study\",\n      \"journal\": \"PLoS neglected tropical diseases\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — functional cellular assays plus primary human PBMC data plus clinical cohort; multiple independent lines of evidence in same study\",\n      \"pmids\": [\"18461142\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TLR1/2 activation by Pam3CSK4 in AML cells induces apoptosis via p38 MAPK-dependent Caspase-3 activation and myeloid differentiation via NF-κB; these effects are p53-independent (shown using Trp53-null AML cells) and selective for leukemic vs. normal hematopoietic stem/progenitor cells.\",\n      \"method\": \"Agonist treatment of primary AML and murine AML cells; p38 MAPK/Caspase-3 assay; NF-κB activation assay; Trp53-/- AML model; in vivo mouse model\",\n      \"journal\": \"Blood advances\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal mechanistic readouts (apoptosis, differentiation, pathway inhibitors) with genetic p53 controls; single lab\",\n      \"pmids\": [\"29296851\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"TLR1 activation in intestinal epithelium is required for induction of TH17 immunity during oral Yersinia enterocolitica infection; TLR2/TLR1-induced IL-6 and IL-23 combined with intestinal TGF-β drives TH17 differentiation, while TLR2/TLR6 drives IL-10+ regulatory T cell responses during both oral and systemic infection.\",\n      \"method\": \"TLR1-/- and TLR6-/- mouse infection model; cytokine measurement; T cell phenotyping\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO epistasis in infection model with defined cytokine and T cell readouts; single lab\",\n      \"pmids\": [\"22778390\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"TLR1 activation in intestinal epithelium upregulates CCL20, recruiting CCR6+ dendritic cells that produce innate cytokines driving TH17 cells and IgA production during oral Y. enterocolitica infection; neutralization of CCL20 or TLR1 deletion both impair CCR6+ DC recruitment and anti-Yersinia TH17/IgA responses.\",\n      \"method\": \"TLR1-/- mouse infection model; CCL20 antibody neutralization; dendritic cell phenotyping; IgA measurement\",\n      \"journal\": \"Mucosal immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO and pharmacological blockade with defined cellular and molecular readouts; single lab\",\n      \"pmids\": [\"23443468\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Mycobacterial lipomannan (LM) induces MMP-9 expression and secretion in human macrophages through a TLR1/TLR2- and CD14-dependent mechanism; LM simultaneously down-regulates TIMP-1, the major endogenous MMP-9 inhibitor.\",\n      \"method\": \"Anti-TLR1 and anti-TLR2 neutralizing antibody blocking; anti-CD14 blocking; ELISA and zymography for MMP-9; RT-PCR for TIMP-1\",\n      \"journal\": \"Infection and immunity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — receptor-blocking antibodies with functional readout in primary and cell-line macrophages; single lab\",\n      \"pmids\": [\"16177394\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The triacylated lipoprotein MG149 from Mycoplasma genitalium activates NF-κB through TLR1 and TLR2; dominant-negative TLR1 but not dominant-negative TLR6 blocks MG149-induced NF-κB activation, and a synthetic triacylated lipopeptide derived from MG149 also signals through TLR1/2.\",\n      \"method\": \"Dominant-negative TLR constructs; NF-κB reporter assay; Triton X-114 protein fractionation\",\n      \"journal\": \"Infection and immunity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — dominant-negative approach with defined TLR specificity; single lab, two lines of evidence (native protein and synthetic lipopeptide)\",\n      \"pmids\": [\"18474641\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"TLR1/2 signaling in cystic fibrosis airway neutrophils upregulates TLR5 surface expression through a mechanism dependent on TLR1 and TLR2 cooperation; antibody blocking of TLR1 or TLR2 abrogates the Pam3CSK4-induced TLR5 upregulation, and elevated TLR5 enhances phagocytosis and respiratory burst via IL-8/CXCR1 signaling.\",\n      \"method\": \"Antibody-blocking experiments; confocal microscopy; flow cytometry; in vitro neutrophil stimulation\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — receptor-blocking antibodies plus imaging and functional assays; single lab\",\n      \"pmids\": [\"18684966\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Defective TLR1 recognition of microbiota-derived ligands by colonic epithelial cells disrupts crypt homeostasis (mucus layer defects, ectopic Paneth cells, increased crypt-base proliferation), increases mucosal-associated and translocating commensal bacteria, and promotes chronic low-grade inflammation mediated by innate lymphoid-like cells that worsen colonic injury.\",\n      \"method\": \"TLR1-/- mouse model; histology; bacterial culture; innate lymphoid cell phenotyping; colitis injury model\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with multiple defined cellular and histological phenotypes in a focused study; single lab\",\n      \"pmids\": [\"29794015\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"In human primary plasmacytoid dendritic cells (pDCs), TLR1 and TLR2 are expressed and respond to gram-positive bacterial lipoproteins via TLR1/2; upregulation of costimulatory molecules and pro-inflammatory cytokines is TLR1-dependent via MAPK and NF-κB pathways, whereas type I IFN secretion is TLR2-dependent via PI3K, revealing a functional dichotomy within the same heterodimer.\",\n      \"method\": \"Antibody blocking of TLR1 vs TLR2; pathway inhibitors (MAPK, NF-κB, PI3K); cytokine/IFN ELISA; primary human pDC culture\",\n      \"journal\": \"PLoS biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological pathway dissection and receptor-specific antibody blocking in primary human cells; single lab, orthogonal inhibitor approaches\",\n      \"pmids\": [\"31017904\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"siRNA knockdown of TLR1 (but not TLR6) in bovine endometrial epithelial and stromal cells reduces IL-6 and IL-8 accumulation in response to triacylated lipopeptides, and inhibitors of ERK1/2 or p38 limit IL-6 production; both lipopeptides rapidly induce phosphorylation of ERK1/2, p38, and NF-κB through TLR2/TLR1 heterodimers in endometrial cells.\",\n      \"method\": \"siRNA knockdown; cytokine ELISA; MAPK/NF-κB phosphorylation assay; kinase inhibitors\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA KD with specific receptor discrimination and downstream pathway analysis; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"24437488\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"miR-15a/16 directly binds the 3'-UTR of TLR1 mRNA and reduces TLR1 protein expression in non-small cell lung cancer cells, thereby downregulating NF-κB signaling pathway activity and enhancing radiosensitivity.\",\n      \"method\": \"Luciferase reporter assay (3'-UTR); miRNA mimic overexpression; immunoblot; NF-κB reporter; in vivo xenograft model\",\n      \"journal\": \"International journal of radiation oncology, biology, physics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — 3'-UTR reporter assay validates direct miRNA-TLR1 interaction; functional consequences shown in vitro and in vivo; single lab\",\n      \"pmids\": [\"25442346\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The spacing of TLR1/2 ligand nanoclusters on an artificial 'phagocytic synapse' array dictates the proximity of TLR1/2 receptor clusters on macrophage surfaces and consequently the magnitude of pro-inflammatory responses; cell responses plateau when ligand spacing is small enough for receptor nanoclusters to become adjacent, demonstrating a physical integration of spatial ligand cues into TLR1/2 signaling.\",\n      \"method\": \"DNA nanoarray platform mimicking cell-microbe interface; fluorescence imaging of receptor clustering; cytokine assay\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — novel nanopatterning platform with direct imaging of receptor distribution linked to functional output; single lab\",\n      \"pmids\": [\"33268354\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TLR1/2 activation by Pam3CSK4 increases Fcγ receptor IV (FcγRIV) expression on macrophages, leading to antibody-dependent macrophage-mediated depletion of regulatory T cells in the tumor microenvironment; this mechanism enhances efficacy of anti-CTLA-4 antibody and requires CD4 T cells, CD8 T cells, FcγRIV, and macrophages.\",\n      \"method\": \"In vivo mouse melanoma model; intratumoral injection; flow cytometry for FcγRIV expression; T cell depletion; tumor-infiltrating leukocyte analysis\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo mechanistic dissection with genetic and cell-depletion controls; single lab\",\n      \"pmids\": [\"31076558\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TLR1 functions as an obligate co-receptor that heterodimerizes with TLR2 to recognize tri-acylated bacterial lipopeptides and lipoproteins: the amide-bound lipid chain of Pam3CSK4 inserts into a hydrophobic channel in TLR1 while ester-bound chains bind TLR2, bringing their intracellular TIR domains into proximity for MyD88-dependent NF-κB and MAPK signaling; TLR1 surface trafficking is regulated by the chaperones PRAT4A (positive) and PRAT4B (negative) via a short cytoplasmic motif at position 602, and the common I602S polymorphism disrupts this motif to impair cell-surface expression and innate immune responses to mycobacteria and other pathogens.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"TLR1 is a pattern-recognition co-receptor that operates as an obligate partner of TLR2, forming a heterodimer that detects tri-acylated bacterial lipopeptides and lipoproteins at the cell surface and initiates innate immune signaling [#0, #13]. TLR1 and TLR2 physically associate co-translationally, independent of ligand, and the crystal structure of the TLR1-TLR2-Pam3CSK4 complex shows an 'm'-shaped heterodimer in which the amide-bound lipid chain of the ligand inserts into a hydrophobic channel in TLR1 while the ester-bound chains occupy a pocket in TLR2, bringing the intracellular TIR domains into proximity for signaling [#0, #1, #2]. Ligand specificity is conferred by the TLR1 extracellular leucine-rich-repeat region (LRR 9-17), which discriminates tri-acylated from di-acylated agonists and distinguishes TLR1- from TLR6-dependent ligands [#9, #11], while a defined TIR-domain interface (TLR1 Gly-676 contacting the TLR2 DD loop) mediates the productive intracellular interaction [#3]. CD14, LBP and soluble CD14 act upstream as mobile carriers that capture lipopeptides and deliver them to the heterodimer, promoting ternary-complex assembly without remaining associated with the final complex [#4, #5]. Engaged TLR1/2 signals through a MyD88-dependent NF-κB and MAPK (ERK1/2, p38) cascade to drive pro-inflammatory cytokine production [#10, #14, #28]. The receptor recognizes a broad range of microbial ligands—mycobacterial lipoarabinomannan and lipomannan, Francisella and Mycoplasma lipoproteins, Borrelia OspA, meningococcal porin PorB and enterotoxin LT-IIb-B5—and is genetically required for lipoprotein but not peptidoglycan responses [#1, #8, #9, #13, #18, #23, #24]. TLR1 cell-surface trafficking depends on a short cytoplasmic motif adjacent to the transmembrane domain and on the ER chaperones PRAT4A (positive) and PRAT4B (negative); the common I602S transmembrane polymorphism disrupts this motif, impairing surface expression and innate responses, an association linked to leprosy susceptibility and rescued by IFN-γ-induced PRAT4A [#6, #7, #19]. Beyond innate sensing, TLR1/2 engagement shapes adaptive and tissue immunity—driving intestinal TH17 differentiation and IgA via epithelial IL-6/IL-23 and CCL20-dependent dendritic-cell recruitment, and maintaining colonic crypt homeostasis through recognition of microbiota ligands [#21, #22, #26].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"Before TLR1's activating role was defined, its first characterized effect was to negatively modulate TLR2 signaling, establishing that TLR1 is a context-dependent modifier of TLR2 responses rather than a uniform amplifier.\",\n      \"evidence\": \"Transfection-based NF-κB reporter and cytokine assays with phenol-soluble modulin\",\n      \"pmids\": [\"11123271\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Does not define the ligands for which TLR1 is activating versus inhibitory\", \"Mechanism of the dampening effect unresolved\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Genetic deletion established TLR1 as specifically required for recognition of tri-acylated lipoproteins while dispensable for peptidoglycan, separating its ligand class from other TLR2 functions.\",\n      \"evidence\": \"TLR1-/- and TLR2-/- mouse immunization with OspA and macrophage cytokine assays\",\n      \"pmids\": [\"12091878\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the structural basis of ligand discrimination\", \"Downstream pathway not dissected\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Co-IP, imaging and domain-swap analyses showed TLR1 and TLR2 form a ligand-independent heterodimer whose TIR domains are the crucial intracellular interaction surface, defining the receptor as an obligate dimer rather than two independent sensors.\",\n      \"evidence\": \"Co-immunoprecipitation, confocal microscopy, receptor cross-linking, chimeric domain-swap and complementation assays\",\n      \"pmids\": [\"12935358\", \"12975352\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic geometry of the dimer not yet resolved\", \"How ligand binding repositions the TIR domains not directly shown\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Live-cell biophysics placed CD14 upstream as the initial lipopeptide-binding step that recruits the ligand to a TLR1/TLR2 low-mobility signaling complex, ordering the recognition cascade.\",\n      \"evidence\": \"FRET/FRAP imaging and flow cytometry in human cells with Pam3CSK4\",\n      \"pmids\": [\"15714590\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of the CD14-TLR complex not defined\", \"Whether CD14 dissociates from the final complex not addressed here\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Mutagenesis and docking identified the specific TIR-domain interface residues (TLR1 Gly-676 / TLR2 DD loop) required for productive signaling, localizing the intracellular interaction at amino-acid resolution.\",\n      \"evidence\": \"Alanine-scanning mutagenesis, computational docking and NF-κB reporter assays\",\n      \"pmids\": [\"16893894\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Interface mapped computationally rather than by structure\", \"Recruitment of MyD88 to this interface not directly shown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Structure-activity analysis with lipopeptide variants and TLR-KO cells refined the acylation model, showing TLR1 dependence requires sufficiently long ester-bound chains and that some di-acylated ligands signal independently of TLR1/TLR6.\",\n      \"evidence\": \"Cytokine assays in TLR1-/- and TLR6-/- mouse cells with synthetic lipopeptide analogs\",\n      \"pmids\": [\"16455646\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural explanation for chain-length requirement provided later by crystallography\", \"Generality across natural ligands not established\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"The crystal structure of the TLR1-TLR2-Pam3CSK4 complex provided the atomic basis for heterodimer assembly and lipid discrimination, showing the amide-bound chain inserts into a hydrophobic channel in TLR1 to bridge the TIR domains.\",\n      \"evidence\": \"X-ray crystallography of the ternary ectodomain complex with functional validation\",\n      \"pmids\": [\"17889651\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not capture the transmembrane or intracellular conformational changes\", \"CD14/LBP delivery step not in the structure\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Domain-exchange analysis localized ligand recognition to TLR1 extracellular LRR 9-17, the region that confers specificity for tri-acylated lipopeptides and Francisella lipoproteins.\",\n      \"evidence\": \"Chimeric TLR1/TLR6 domain-exchange and NF-κB reporter assays\",\n      \"pmids\": [\"18079113\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Individual contact residues within the region not all mapped\", \"Affinity contributions of the LRR region not quantified\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Identification of the I602S transmembrane polymorphism linked a natural human variant to defective TLR1 surface trafficking and diminished agonist responses, connecting receptor cell biology to disease susceptibility.\",\n      \"evidence\": \"Flow cytometry, NF-κB reporter, whole-blood cytokine assays and a leprosy genetic association study\",\n      \"pmids\": [\"17548585\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular trafficking machinery not yet identified\", \"Mechanism by which a transmembrane residue controls surface delivery unresolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Functional and clinical analysis tied the I602S (1805G) allele to impaired NF-κB responses to M. leprae and to altered leprosy reversal-reaction risk, extending the trafficking defect to adaptive Th1 immunity.\",\n      \"evidence\": \"NF-κB reporter in HEK293, PBMC cytokine assays and a clinical genetic cohort\",\n      \"pmids\": [\"18461142\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Causal chain from reduced surface TLR1 to Th1 outcome correlative\", \"Effect sizes vary across pathogen contexts\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Mechanistic dissection identified the short cytoplasmic trafficking motif disrupted by I602S and the opposing ER chaperones PRAT4A and PRAT4B, and showed IFN-γ rescues surface expression in variant monocytes, defining the regulatory logic of TLR1 surface delivery.\",\n      \"evidence\": \"Point mutagenesis, PRAT4A/B overexpression and knockdown, and IFN-γ treatment of primary human monocytes\",\n      \"pmids\": [\"22447933\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct chaperone-TLR1 contact sites not mapped\", \"How the cytoplasmic motif is read by the trafficking machinery unresolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"In vitro reconstitution defined LBP and soluble CD14 as independent mobile carriers that transfer lipopeptides to the receptor and enhance ternary-complex formation without remaining bound, refining the ligand-delivery model.\",\n      \"evidence\": \"Size-exclusion chromatography of recombinant soluble TLR ectodomains with cell activation assays\",\n      \"pmids\": [\"23430250\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinetics of carrier handoff not quantified\", \"Relative contributions of LBP versus sCD14 in vivo unclear\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Crystallography of the synthetic agonist Diprovocim showed a non-lipopeptide ligand can drive TLR2/TLR1 dimerization through the TLR2 ectodomain pocket, establishing that the receptor can be activated by non-canonical chemistries.\",\n      \"evidence\": \"Crystal structure and in vitro biophysical assays of the TLR2-Diprovocim complex\",\n      \"pmids\": [\"30829478\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"TLR1's contribution to the Diprovocim-bound complex less defined than in the lipopeptide structure\", \"In vivo activity not addressed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How TLR1's defined molecular recognition is translated into the divergent tissue- and disease-specific outcomes (TH17 versus regulatory responses, leukemic apoptosis, anti-tumor macrophage reprogramming, crypt homeostasis) at the level of signaling specificity remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether identical NF-κB/MAPK output can account for divergent cell-type outcomes is unexplained\", \"No structural model linking ligand identity to differential downstream programs\", \"Mechanism of the receptor-level TLR1/TLR2 functional dichotomy in pDCs not defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 1, 13]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [0, 5, 11]},\n      {\"term_id\": \"GO:0001618\", \"supporting_discovery_ids\": [8, 18]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [2, 4, 6, 30]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [7]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 1, 13, 27]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [10, 14, 28]}\n    ],\n    \"complexes\": [\"TLR1-TLR2 heterodimer\"],\n    \"partners\": [\"TLR2\", \"CD14\", \"LBP\", \"MYD88\", \"PRAT4A\", \"PRAT4B\"],\n    \"other_free_text\": []\n  }\n}\n```","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}